1 Day CRL -3.37% DJIA 0.01% S&P 500 0.16% Health Care/Life Sciences 0.13% ...

The FDA issued a second CRL for rivoceranib and camrelizumab, with undisclosed reasons for non-approval. The combination therapy showed improved overall survival and progression-free survival ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Citi upgraded Charles River Laboratories (NYSE:CRL) and LabCorp (NYSE:LH) while downgrading Quest Diagnostics (NYSE:DGX), citing valuation-related arguments as the main reasons for the rating ...

(NYSE:CRL) stands against the other best diagnostics stocks to invest in right now. According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of ...

"Our team is evaluating the feedback provided and intends to request a Type A meeting to discuss the issues raised in the CRL," said Joe Oliveto, President and CEO of Milestone Pharmaceuticals.

Newly available in a chic and sophisticated Matte Black finish, the CRL Paris System offers a simple, stylish and streamlined solution for anyone looking to install a French balcony. Extending the ...

After hours: 5:48:21 p.m. EDT Loading Chart for CRL ...